Analyze Diet
Veterinary microbiology2012; 159(3-4); 381-389; doi: 10.1016/j.vetmic.2012.04.010

Antimicrobial resistance in faecal Escherichia coli isolates from horses treated with antimicrobials: a longitudinal study in hospitalised and non-hospitalised horses.

Abstract: The objective of this study was to examine the emergence and persistence of antimicrobial resistant faecal Escherichia coli in horses treated with antimicrobial drugs in a hospital and community setting. Faecal samples were collected from hospitalised (n=56) and non-hospitalised (n=14) horses treated with antimicrobials, and 10 non-treated hospitalised controls. Samples were obtained pre-treatment and 5 days later in all horses, and 2 weeks and 2 months after treatment in treated horses. Susceptibility to 15 antimicrobials was tested via disc diffusion on up to 3 E. coli isolates per sample. Phenotypic extended spectrum beta-lactamase (ESBL) production was identified via a combination disc method, and ESBL-encoding sequences identified by PCR. A resistant E. coli isolate was identified in 138/228 (60.5%) samples. The proportion of resistant samples was not significantly different between hospitalised and non-hospitalised treated horses. The odds of a sample containing a resistant isolate increased significantly at day 5 in treated horses, but not in controls. Two weeks following treatment, the odds of resistance in non-hospitalised horses returned to pre-treatment levels, but remained significantly above pre-treatment levels in hospital-treated horses, returning to base-line 2 months after treatment. Seven samples (17 isolates) were positive for ESBL production. The genes bla(CTX-M) and bla(TEM) were identified in 12/17 isolates, with bla(SHV) in 4/17. Antimicrobial administration to horses in hospital and community settings is associated with an increased but transient risk of faecal shedding of antimicrobial-resistant E. coli. The high prevalence of resistant isolates suggests that methods to minimise their potential spread should be considered.
Publication Date: 2012-04-17 PubMed ID: 22565010DOI: 10.1016/j.vetmic.2012.04.010Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The study investigates the rise and persistence of drug-resistant E. coli in horses treated with antibiotics. The results indicated that antibiotic treatment in horses, both in hospital and community settings, increased the risk of faecal shedding of drug-resistant E. coli but this is usually temporary.

Objective of the Study

  • The primary purpose of this research was to investigate the occurrence and persistence of antibiotic-resistant Escherichia coli, commonly known as E. coli, in the stool of horses treated with antibiotics in both hospital and community settings.

Methodology

  • Stool samples were collected from horses either hospitalised or treated outside the hospital and from untreated horses as control.
  • Samples were taken before treatment, five days after treatment, and again at two weeks and two months after treatment in treated horses.
  • The resistance of the E. coli in the stool samples to 15 different antibiotics was tested through a method called disc diffusion, while additional tests were performed to identify specific antibiotic-resistant genes.

Findings

  • Resistance to antibiotics was found in 60.5% of all samples, with no significant difference between those from hospitalised and non-hospitalised horses.
  • The likelihood of a sample containing a drug-resistant strain significantly increased five days after treatment in treated horses but not in untreated horses.
  • Two weeks after treatment, resistance in non-hospitalised horses returned to pre-treatment levels. In hospital-treated horses, it remained significantly higher than pre-treatment level but returned to baseline two months after treatment.
  • In seven samples (17 isolates), production of extended-spectrum beta-lactamases (ESBL), which are enzymes that confer resistance to most beta-lactam antibiotics, was observed. Within these, two specific resistance genes were identified – bla(CTX-M) and bla(TEM).

Implications

  • The results of this study indicate that the use of antibiotics in horses increases the risk of the emergence of drug-resistant E. coli, though this effect is usually transient.
  • The widespread prevalence of resistant strains suggests a need for measures to minimise potential spread. This could include better antibiotic stewardship and hygiene protocols, especially in hospitals where such resistance can pose a danger to other animals.

Cite This Article

APA
Johns I, Verheyen K, Good L, Rycroft A. (2012). Antimicrobial resistance in faecal Escherichia coli isolates from horses treated with antimicrobials: a longitudinal study in hospitalised and non-hospitalised horses. Vet Microbiol, 159(3-4), 381-389. https://doi.org/10.1016/j.vetmic.2012.04.010

Publication

ISSN: 1873-2542
NlmUniqueID: 7705469
Country: Netherlands
Language: English
Volume: 159
Issue: 3-4
Pages: 381-389

Researcher Affiliations

Johns, Imogen
  • Department of Veterinary Clinical Sciences, Royal Veterinary College, Hawkshead Lane, North Mymms, AL9 7TA, United Kingdom. ijohns@rvc.ac.uk
Verheyen, Kristien
    Good, Liam
      Rycroft, Andrew

        MeSH Terms

        • Animals
        • Anti-Bacterial Agents / therapeutic use
        • Bacterial Shedding
        • Drug Resistance, Bacterial
        • Drug Resistance, Multiple, Bacterial
        • Escherichia coli / drug effects
        • Escherichia coli / enzymology
        • Escherichia coli / genetics
        • Escherichia coli / isolation & purification
        • Escherichia coli Infections / microbiology
        • Escherichia coli Infections / veterinary
        • Feces / microbiology
        • Horse Diseases / microbiology
        • Horses
        • Longitudinal Studies
        • beta-Lactamases / metabolism

        Citations

        This article has been cited 11 times.
        1. Theelen MJP, Luiken REC, Wagenaar JA, Sloet van Oldruitenborgh-Oosterbaan MM, Rossen JWA, Schaafstra FJWC, van Doorn DA, Zomer AL. Longitudinal study of the short- and long-term effects of hospitalisation and oral trimethoprim-sulfadiazine administration on the equine faecal microbiome and resistome.. Microbiome 2023 Feb 27;11(1):33.
          doi: 10.1186/s40168-023-01465-6pubmed: 36850017google scholar: lookup
        2. Effendi MH, Hartadi EB, Witaningrum AM, Permatasari DA, Ugbo EN. Molecular identification of blaTEM gene of extended-spectrum beta-lactamase-producing Escherichia coli from healthy pigs in Malang district, East Java, Indonesia.. J Adv Vet Anim Res 2022 Sep;9(3):447-452.
          doi: 10.5455/javar.2022.i613pubmed: 36382042google scholar: lookup
        3. Thomson K, Eskola K, Eklund M, Suominen K, Määttä M, Junnila J, Nykäsenoja S, Niinistö K, Grönthal T, Rantala M. Characterisation of and risk factors for extended-spectrum β-lactamase producing Enterobacterales (ESBL-E) in an equine hospital with a special reference to an outbreak caused by Klebsiella pneumoniae ST307:CTX-M-1.. Acta Vet Scand 2022 Feb 9;64(1):4.
          doi: 10.1186/s13028-022-00621-6pubmed: 35139865google scholar: lookup
        4. Reshadi P, Heydari F, Ghanbarpour R, Bagheri M, Jajarmi M, Amiri M, Alizade H, Badouei MA, Sahraei S, Adib N. Molecular characterization and antimicrobial resistance of potentially human-pathogenic Escherichia coli strains isolated from riding horses.. BMC Vet Res 2021 Mar 25;17(1):131.
          doi: 10.1186/s12917-021-02832-xpubmed: 33766016google scholar: lookup
        5. Shnaiderman-Torban A, Navon-Venezia S, Dor Z, Paitan Y, Arielly H, Ahmad WA, Kelmer G, Fulde M, Steinman A. Extended-Spectrum β-lactamase-Producing Enterobacteriaceae Shedding in Farm Horses Versus Hospitalized Horses: Prevalence and Risk Factors.. Animals (Basel) 2020 Feb 11;10(2).
          doi: 10.3390/ani10020282pubmed: 32054111google scholar: lookup
        6. Theelen MJP, Wilson WD, Byrne BA, Edman JM, Kass PH, Mughini-Gras L, Magdesian KG. Differences in isolation rate and antimicrobial susceptibility of bacteria isolated from foals with sepsis at admission and after ≥48 hours of hospitalization.. J Vet Intern Med 2020 Mar;34(2):955-963.
          doi: 10.1111/jvim.15692pubmed: 32022351google scholar: lookup
        7. Potier JFN, Durham AE. Antimicrobial susceptibility of bacterial isolates from ambulatory practice and from a referral hospital.. J Vet Intern Med 2020 Jan;34(1):300-306.
          doi: 10.1111/jvim.15685pubmed: 31849110google scholar: lookup
        8. Trigo da Roza F, Couto N, Carneiro C, Cunha E, Rosa T, Magalhães M, Tavares L, Novais Â, Peixe L, Rossen JW, Lamas LP, Oliveira M. Commonality of Multidrug-Resistant Klebsiella pneumoniae ST348 Isolates in Horses and Humans in Portugal.. Front Microbiol 2019;10:1657.
          doi: 10.3389/fmicb.2019.01657pubmed: 31379799google scholar: lookup
        9. de Lagarde M, Larrieu C, Praud K, Schouler C, Doublet B, Sallé G, Fairbrother JM, Arsenault J. Prevalence, risk factors, and characterization of multidrug resistant and extended spectrum β-lactamase/AmpC β-lactamase producing Escherichia coli in healthy horses in France in 2015.. J Vet Intern Med 2019 Mar;33(2):902-911.
          doi: 10.1111/jvim.15415pubmed: 30648296google scholar: lookup
        10. Toombs-Ruane LJ, Riley CB, Kendall AT, Bolwell CF, Benschop J, Rosanowski SM. Antimicrobial Susceptibilities of Aerobic Isolates from Respiratory Samples of Young New Zealand Horses.. J Vet Intern Med 2015 Nov-Dec;29(6):1700-6.
          doi: 10.1111/jvim.13600pubmed: 26289293google scholar: lookup
        11. Schmiedel J, Falgenhauer L, Domann E, Bauerfeind R, Prenger-Berninghoff E, Imirzalioglu C, Chakraborty T. Multiresistant extended-spectrum β-lactamase-producing Enterobacteriaceae from humans, companion animals and horses in central Hesse, Germany.. BMC Microbiol 2014 Jul 12;14:187.
          doi: 10.1186/1471-2180-14-187pubmed: 25014994google scholar: lookup